Phase 1 9 trials · 1 met primary
Phase 1
NCT07338487 Apr → Dec 2026 expected cervical cancer , hypoproteinemia, hypercatabolic Second Xiangya Hospital of Central South University
Recruiting
No outcome recorded
Phase 1
NCT07130617 Sep 2025 → Jul 2026 overdue —
Changchun GeneScience Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 1
NCT05332483 Jul 2022 → Oct 2023 endometrial cancer Sunnybrook Health Sciences Centre
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT06147908 Jul → Oct 2022 —
Daewon Pharmaceutical Co., Ltd.
Completed
Met primary
Phase 1
NCT01383330 Jul → Sep 2011 —
Asan Medical Center
Unknown
No outcome recorded
Phase 1
NCT01342055 Mar → May 2011 —
LG Life Sciences
Completed
No outcome recorded
Phase 1
NCT02446353 Apr → Jun 2010 —
LG Life Sciences
Completed
Mixed
Phase 1
NCT00637403 May 2006 —
Par Pharmaceutical, Inc.
Terminated
No outcome recorded
Phase 1
NCT00000737 — HIV wasting syndrome , hypoproteinemia, hypercatabolic National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1/2 2 trials
Phase 1/2
NCT05538897 Mar 2023 → Jan 2027 expected endometrial endometrioid adenocarcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT00002465 Dec 1987 → ? breast cancer , endometrial cancer , malignant mesothelioma St. Vincent Medical Center - Los Angeles
Unknown
No outcome recorded
Phase 2 34 trials · 2 met primary · 1 missed
Phase 2
NCT07565415 Jun 2026 → Sep 2027 expected hepatocellular carcinoma , hypoproteinemia, hypercatabolic , nutritional disorder Nanfang Hospital, Southern Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT07391826 Feb → Dec 2026 expected gastric carcinoma The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT07377734 Jan 2026 → Dec 2027 expected atypical endometrial hyperplasia , endometrial cancer Wang Jianliu
Recruiting
No outcome recorded
Phase 2
NCT07246070 Dec 2025 → Aug 2026 overdue chemotherapy-induced toxicity Aiping Zhou
Not yet recruiting
No outcome recorded
Phase 2
NCT07092137 Oct 2025 → Oct 2026 expected lung cancer Guangzhou Institute of Respiratory Disease
Not yet recruiting
No outcome recorded
Phase 2
NCT06979596 Aug 2025 → Nov 2027 expected cancer Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 2
NCT06909383 Jun 2025 → Jun 2026 overdue paraneoplastic gastrointestinal syndrome , small cell lung carcinoma Guangzhou Institute of Respiratory Disease
Not yet recruiting
No outcome recorded
Phase 2
NCT06914297 Apr 2025 → Oct 2027 expected endometrial cancer Fudan University
Recruiting
No outcome recorded
Phase 2
NCT06793228 Jan 2025 → Jan 2027 expected small cell lung carcinoma Henan Cancer Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT05913427 Jun 2022 → Jun 2027 expected adrenal cortex carcinoma Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Recruiting
No outcome recorded
Phase 2
NCT04576104 Nov 2021 → Aug 2025 overdue atypical endometrial hyperplasia , endometrial carcinoma Northwestern University
Active not recruiting
No outcome recorded
Phase 2
NCT04491643 Sep 2020 → Aug 2023 endometrial carcinoma Fudan University
Completed
No outcome recorded
Phase 2
NCT05492487 Jan 2020 → Mar 2023 atypical endometrial hyperplasia , infertility disorder KK Women's and Children's Hospital
Unknown
Met primary
Phase 2
NCT03671811 Jan 2019 → Dec 2022 overdue atypical endometrial hyperplasia , endometrial carcinoma City of Hope Medical Center
Active not recruiting
Missed primary
Phase 2
NCT04430361 Sep 2018 → Dec 2020 chemotherapy-induced toxicity , neoplasm Henan Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT03306472 Jul 2017 → Oct 2022 breast cancer Cambridge University Hospitals NHS Foundation Trust
Completed
Met primary
Phase 2
NCT03077698 Jun 2017 → Jul 2020 endometrial cancer Xenetic Biosciences, Inc.
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT03024580 Mar 2017 → Mar 2020 breast neoplasm Brazilian National Cancer Institute
Unknown
No outcome recorded
Phase 2
NCT02980653 May 2015 → Aug 2017 head and neck cancer TTY Biopharm
Unknown
No outcome recorded
Phase 2
NCT01943058 Mar 2014 → Oct 2016 atypical endometrial hyperplasia , endometrium adenocarcinoma University of Southern California
Withdrawn
No outcome recorded
Stop: Business
Phase 2
NCT01968317 Oct 2013 → Oct 2017 atypical endometrial hyperplasia , endometrium adenocarcinoma Xiaojun Chen
Completed
No outcome recorded
Phase 2
NCT01501396 Sep 2013 → Sep 2015 eating disorder Washington University School of Medicine
Withdrawn
No outcome recorded
Phase 2
NCT01200602 Mar → Nov 2011 eating disorder Mayo Clinic
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00729586 Sep 2008 → Feb 2017 endometrial carcinoma , uterine corpus cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00503581 Jul 2007 → Jul 2012 squamous cell intraepithelial neoplasia , uterus carcinoma in situ Gynecologic Oncology Group
Terminated
No outcome recorded
Phase 2
NCT00483327 Jun 2007 → Oct 2013 atypical endometrial hyperplasia , endometrial carcinoma NYU Langone Health
Completed
No outcome recorded
Phase 2
NCT00507949 Oct 2006 → Apr 2009 chronic obstructive pulmonary disease Rottapharm Spain
Completed
No outcome recorded
Phase 2
NCT00637572 Dec 2004 → Jun 2005 HIV wasting syndrome , eating disorder Endo USA Inc., a Keenova Therapeutics Company
Completed
No outcome recorded
Phase 2
NCT00584857 Jul 2004 → Oct 2010 uterine cancer University of Alabama at Birmingham
Completed
No outcome recorded
Phase 2
NCT00066248 Jun 2003 → Aug 2007 childhood malignant neoplasm , hypoproteinemia, hypercatabolic , leukemia , lymphoma +3 University of South Florida
Completed
No outcome recorded
Phase 2
NCT00004912 Jan 2000 → Nov 2003 HIV wasting syndrome , cancer of unknown primary site Northwestern University
Completed
No outcome recorded
Phase 2
NCT00002680 Feb 1994 → Dec 2000 breast cancer Yale University
Completed
No outcome recorded
Phase 2
NCT00002300 — HIV wasting syndrome , anorexia nervosa Bristol-Myers Squibb
Completed
No outcome recorded
Phase 2
NCT00001079 ? → Dec 2002 HIV wasting syndrome National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Show 24 more trials Phase 2/3 8 trials · 2 missed
Phase 2/3
NCT07319429 Jan 2026 → Dec 2027 expected endometrial cancer , infertility disorder Fudan University
Recruiting
No outcome recorded
Phase 2/3
NCT05316493 Jun 2022 → Feb 2026 overdue atypical endometrial hyperplasia , infertility disorder Xiaojun Chen
Recruiting
No outcome recorded
Phase 2/3
NCT05316467 May 2022 → Feb 2026 endometrial carcinoma , female infertility , obesity disorder Xiaojun Chen
Terminated
No outcome recorded
Stop: Enrollment
Phase 2/3
NCT04683237 Mar 2021 → Nov 2025 atypical endometrial hyperplasia , infertility disorder , obesity disorder Xiaojun Chen
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 2/3
NCT04491682 Sep 2020 → Jun 2022 atypical endometrial hyperplasia Fudan University
Completed
No outcome recorded
Phase 2/3
NCT03241914 Jul 2017 → Jun 2020 stage I endometrioid carcinoma Fudan University
Completed
Missed primary
Phase 2/3
NCT03241888 Jul 2017 → Jun 2020 atypical endometrial hyperplasia Fudan University
Completed
Missed primary
Phase 2/3
NCT00503516 Jun 2007 → Dec 2009 dementia Rottapharm Spain
Terminated
No outcome recorded
Stop: Enrollment
Phase 3 19 trials · 2 missed
Phase 3
NCT07796789 Aug 2026 → Aug 2027 expected nasopharyngeal carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 3
NCT07831902 Jun 2026 → Dec 2030 expected endometrial cancer University College, London
Recruiting
No outcome recorded
Phase 3
NCT07543536 May 2026 → Apr 2029 expected breast cancer Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 3
NCT07477808 Apr 2026 → Apr 2028 expected non-small cell lung carcinoma Hunan Province Tumor Hospital
Not yet recruiting
No outcome recorded
Phase 3
NCT07356037 Jan 2026 → Jun 2027 expected HIV wasting syndrome , hepatocellular carcinoma Changchun GeneScience Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06998758 Nov 2025 → May 2027 expected —
Sixth Affiliated Hospital, Sun Yat-sen University
Recruiting
No outcome recorded
Phase 3
NCT07150663 Aug 2025 → Jun 2027 expected non-small cell lung carcinoma Changchun GeneScience Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06961188 Jun 2025 → Jun 2027 expected non-small cell lung carcinoma Changchun GeneScience Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06828757 May 2025 → Dec 2026 expected non-small cell lung carcinoma Hunan Province Tumor Hospital
Not yet recruiting
No outcome recorded
Phase 3
NCT06961201 May 2025 → Dec 2026 expected small cell lung carcinoma Changchun GeneScience Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06772428 Jan 2025 → Jun 2027 expected head and neck squamous cell carcinoma Changchun GeneScience Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06500234 Jun 2024 → May 2025 overdue cancer , nutritional disorder Qingdao Central Hospital
Recruiting
No outcome recorded
Phase 3
NCT02644408 Oct 2014 → Dec 2019 esophageal squamous cell carcinoma The First Affiliated Hospital of Henan University of Science and Technology
Completed
No outcome recorded
Phase 3
NCT00041275 May 2002 → Jun 2007 liver cancer National Medical Research Council (NMRC), Singapore
Completed
Missed primary
Phase 3
NCT00016341 May 2001 → Oct 2003 endometrial cancer Gynecologic Oncology Group
Terminated
No outcome recorded
Phase 3
NCT00006799 Oct 2000 → Sep 2002 eating disorder , head and neck cancer Wake Forest University Health Sciences
Completed
No outcome recorded
Phase 3
NCT00031785 Sep 2000 → Sep 2002 eating disorder , hypoproteinemia, hypercatabolic , lung cancer Wake Forest University Health Sciences
Completed
No outcome recorded
Phase 3
NCT00031707 Mar 2000 → Jan 2004 eating disorder , hypoproteinemia, hypercatabolic Alliance for Clinical Trials in Oncology
Completed
Missed primary
Phase 3
NCT00002067 — HIV wasting syndrome , eating disorder Bristol-Myers Squibb
Completed
No outcome recorded
Show 9 more trials Phase 4 10 trials · 1 met primary
Phase 4
NCT07462663 Jan 2027 → Apr 2031 expected atypical endometrial hyperplasia , endometrial cancer , intraepithelial neoplasia , morbid obesity Hospital Universitari de Bellvitge
Not yet recruiting
No outcome recorded
Phase 4
NCT07254416 Dec 2025 → Dec 2026 expected —
Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 4
NCT07243379 Sep 2025 → Dec 2026 expected —
Changchun GeneScience Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 4
NCT06963593 Jun 2025 → Jun 2027 expected gastroesophageal cancer Peking University
Not yet recruiting
No outcome recorded
Phase 4
NCT03815019 Aug 2019 → Mar 2025 eating disorder University of Kansas Medical Center
Completed
No outcome recorded
Phase 4
NCT03963752 Aug 2019 → Aug 2022 idiopathic central precocious puberty Children's Hospital of Fudan University
Completed
No outcome recorded
Phase 4
NCT03777930 Dec 2018 → Oct 2020 cancer-related condition Shenzhen Fifth People's Hospital
Unknown
No outcome recorded
Phase 4
NCT02595723 Jul 2015 → Nov 2016 cognitive impairment with or without cerebellar ataxia University of Texas Southwestern Medical Center
Completed
Met primary
Phase 4
NCT00163072 Oct 2005 → Dec 2012 hypoproteinemia, hypercatabolic Milton S. Hershey Medical Center
Withdrawn
No outcome recorded
Phase 4
NCT00002345 — HIV infectious disease , eating disorder , hypoproteinemia, hypercatabolic Bristol-Myers Squibb
Completed
No outcome recorded
Phase not applicable 8 trials
— NCT07408505 Jun 2026 → Dec 2027 expected pancreatic ductal adenocarcinoma Shandong Cancer Hospital and Institute
Recruiting
No outcome recorded
— NCT06830018 Jan 2025 → Jan 2026 overdue —
Changchun GeneScience Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
— NCT06549855 Oct 2024 → Jul 2029 expected endometrial cancer , endometrioid adenocarcinoma Peking University People's Hospital
Not yet recruiting
No outcome recorded
— NCT06468215 Jul 2024 → Jul 2028 expected endometrial endometrioid adenocarcinoma Peking University People's Hospital
Not yet recruiting
No outcome recorded
— NCT05945407 Aug 2016 → Dec 2023 overdue endometrial cancer , endometrial endometrioid adenocarcinoma Peking University People's Hospital
Recruiting
No outcome recorded
— NCT00575029 Apr → Dec 2004 adrenocortical insufficiency University of Arkansas
Completed
No outcome recorded
— NCT00004664 Jun 1995 → ? AIDS , HIV wasting syndrome National Center for Research Resources (NCRR)
Completed
No outcome recorded
— NCT00002182 — HIV infectious disease Gamma Project - ACTU
Completed
No outcome recorded
Comparator or background therapy 27 trials
Phase 1
NCT01589562 Comparator Apr → Jun 2012 —
Daewon Pharmaceutical Co., Ltd.
Completed
No outcome recorded
Phase 1
NCT01456624 Comparator Sep 2011 → Jun 2012 —
Asan Medical Center
Completed
No outcome recorded
Phase 1
NCT01397214 Comparator Jul → Sep 2011 eating disorder , hypoproteinemia, hypercatabolic Boryung Pharmaceutical Co., Ltd
Completed
No outcome recorded
Phase 1
NCT00638079 Comparator Jun → Jul 2006 —
Endo USA Inc., a Keenova Therapeutics Company
Completed
No outcome recorded
Phase 2
NCT07714070 Background Jul 2026 → Sep 2027 expected atypical endometrial hyperplasia , endometrial cancer , progesterone resistance Peking University People's Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07436793 Comparator Jun 2026 → Jun 2030 expected endometrial disorder , endometrial endometrioid adenocarcinoma New Mexico Cancer Research Alliance
Recruiting
No outcome recorded
Phase 2
NCT05380479 Comparator Jun 2022 → Jan 2023 eating disorder Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Unknown
No outcome recorded
Phase 2
NCT05247268 Comparator Mar 2022 → Mar 2027 expected endometrial carcinoma Fudan University
Recruiting
No outcome recorded
Phase 2
NCT03283488 Comparator Mar 2019 → Feb 2022 eating disorder , hypoproteinemia, hypercatabolic University of Sao Paulo
Completed
No outcome recorded
Phase 2
NCT02269670 Background Nov 2014 → Jan 2021 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma , progesterone-receptor positive breast cancer Emory University
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT02064725 Background Sep 2014 → Jan 2018 endometrial carcinoma Kevelt AS
Unknown
No outcome recorded
Phase 2
NCT01206478 Background Aug 2010 → Dec 2014 avoidant/restrictive food intake disorder Ann Davis, PhD, MPH, ABPP
Completed
No outcome recorded
Phase 2
NCT00420563 Comparator Sep 2009 → Jan 2011 cancer Centre Oscar Lambret
Completed
No outcome recorded
Phase 2
NCT00910091 Comparator Aug 2009 → Jan 2012 endometrial cancer Ipsen
Completed
No outcome recorded
Phase 2
NCT00739830 Comparator Aug 2008 → Feb 2011 endometrial cancer Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 2/3
NCT04607252 Comparator Jan → Jun 2021 atypical endometrial hyperplasia Fudan University
Terminated
No outcome recorded
Phase 2/3
NCT04385667 Comparator May 2020 → Dec 2022 atypical endometrial hyperplasia Zagazig University
Completed
No outcome recorded
Phase 2/3
NCT02619266 Comparator Dec 2015 → Dec 2016 eating disorder Xinqiao Hospital of Chongqing
Unknown
No outcome recorded
Phase 3
NCT06671548 Background Jan 2024 → Nov 2026 expected leiomyoma Qilu Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT04897217 Comparator Jun 2023 → Oct 2024 atypical endometrial hyperplasia Wake Forest University Health Sciences
Withdrawn
No outcome recorded
Phase 3
NCT04939090 Comparator Jan 2022 → Apr 2027 expected cancer , hematopoietic and lymphoid cell neoplasm Alliance for Clinical Trials in Oncology
Active not recruiting
No outcome recorded
Phase 3
NCT00637728 Comparator Jun → Sep 2006 eating disorder Par Pharmaceutical, Inc.
Terminated
No outcome recorded
Phase 3
NCT00637806 Comparator Jun → Sep 2006 —
Par Pharmaceutical, Inc.
Terminated
No outcome recorded
Phase 3
NCT00070148 Comparator Mar 2004 → Aug 2007 cancer of unknown primary site Wake Forest University Health Sciences
Completed
No outcome recorded
Phase 3
NCT01237327 Comparator Nov 2001 → Dec 2007 breast cancer Pfizer
Completed
Missed primary
Phase 3
NCT00005975 Comparator Apr 1998 → Sep 2001 female breast carcinoma SWOG Cancer Research Network
Completed
No outcome recorded
— NCT06417736 Background Dec 2023 → Jul 2025 overdue endometrial cancer Women's Hospital School Of Medicine Zhejiang University
Recruiting
No outcome recorded
Show 22 more trials